Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position

Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets

Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer

Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform

Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches

Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms

Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications

Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study

Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants

Top Penny Stocks Chart Patterns to Use to Profit

Penny Stock Due Diligence: Top Research Techniques

Buying Energy Penny Stocks? 3 Methods to Use

3 Hot Penny Stocks to Add to Your Small-Caps Watch List This Week

Best Penny Stocks, How To Buy & Strategies for Beginners

What Are Penny Stocks? What You Need to Know and 3 to Watch

Best Penny Stocks To Buy This Week? 4 Short Squeeze Stocks To Watch

3 Reddit Penny Stocks For Your Watch List In January 2022

4 Penny Stocks To Buy For Under $5 With High Short Interest

Top Penny Stocks to Buy Now? Check These 3 Out For the New Year